Back
Cabaletta Bio Vs. EyePoint Pharmaceuticals Industry Stock Comparison
Sell
32
CABA
Cabaletta Bio
Last Price:
$1.87
Seasonality Move:
-1.36%
Sell
40
EYPT
EyePoint Pharmaceuticals
Last Price:
$8.82
Seasonality Move:
-0.28%
Sell
32
Cabaletta Bio (CABA)
is a Sell
Is Cabaletta Bio a Buy, Sell or Hold?
-
The current Cabaletta Bio [CABA] share price is $1.94. The Score for CABA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
CABA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
-
The current EyePoint Pharmaceuticals [EYPT] share price is $8.90. The Score for EYPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CABA Stock Price Chart
What is Cabaletta Bio's stock price today?
-
The Cabaletta Bio share price today is $1.94The current trend is moderately bearish and CABA is experiencing slight buying pressure.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $8.90The current trend is moderately bullish and EYPT is experiencing slight selling pressure.
CABA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.12 | Buy |
Relative Strength Index (14 RSI): | 51.87 | Buy |
Chaikin Money Flow: | 925712 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.6 - 2.2) | Buy |
Bollinger Bands (100): | (1.31 - 2.27) | Buy |
EYPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.76 | Buy |
Relative Strength Index (14 RSI): | 69.93 | Buy |
Chaikin Money Flow: | -71262 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.89 - 8.57) | Buy |
Bollinger Bands (100): | (5.5 - 7.68) | Buy |
CABA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.11 | Sell |
20-day SMA: | 1.99 | Sell |
50-day SMA: | 1.55 | Buy |
200-day SMA: | 2.74 | Sell |
8-day EMA: | 2.01 | Sell |
20-day EMA: | 1.94 | Sell |
50-day EMA: | 1.78 | Buy |
200-day EMA: | 3.53 | Sell |
EYPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.87 | Buy |
20-day SMA: | 7.58 | Buy |
50-day SMA: | 6.58 | Buy |
200-day SMA: | 7.78 | Buy |
8-day EMA: | 8.7 | Buy |
20-day EMA: | 7.92 | Buy |
50-day EMA: | 7.11 | Buy |
200-day EMA: | 8.02 | Buy |
Cabaletta Bio Earnings Growth & CABA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.14 per share, and an increase next year of $0.24 per share.
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.09 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.
Cabaletta Bio Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
EyePoint Pharmaceuticals Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |